Buy, Sell or Hold: Nanalysis Scientific Corp. (NSCI-X)

Home

Daily Stock Opinions and Ratings

Nanalysis Scientific Corp. (NSCI-X)

CVE:NSCI

0.29

0.01 (3.57%) 1d

Nervous markets await Nvidia

BUY

They take a large nuclear magnetic resonance machine and shrink it down to a desk top size. They now have a high def version. Theirs is better than their nearest competitor. It won't be profitable until 2021.

Showing 1 to 1 of 1 entries

Nanalysis Scientific Corp.(NSCI-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Nanalysis Scientific Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Nanalysis Scientific Corp.(NSCI-X) Frequently Asked Questions

What is Nanalysis Scientific Corp. stock symbol?

Nanalysis Scientific Corp. is a Canadian stock, trading under the symbol NSCI-X on the TSX Venture Exchange (NSCI-CV). It is usually referred to as TSXV:NSCI or NSCI-X

Is Nanalysis Scientific Corp. a buy or a sell?

In the last year, there was no coverage of Nanalysis Scientific Corp. published on Stockchase.

Is Nanalysis Scientific Corp. a good investment or a top pick?

Nanalysis Scientific Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Nanalysis Scientific Corp..

Why is Nanalysis Scientific Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Nanalysis Scientific Corp. worth watching?

In the last year, there was no coverage of Nanalysis Scientific Corp. published on Stockchase.

What is Nanalysis Scientific Corp. stock price?

On 2025-05-23, Nanalysis Scientific Corp. (NSCI-X) stock closed at a price of $0.29.

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

Stockchase Insights

5i Research

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Jim Lebenthal

Cerity Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.